7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Diabetic Nephropathies D003928 39 associated lipids
Diabetic Neuropathies D003929 5 associated lipids
Diarrhea D003967 32 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Disease Susceptibility D004198 12 associated lipids
Emphysema D004646 1 associated lipids
Encephalitis D004660 15 associated lipids
Endocrine System Diseases D004700 4 associated lipids
Endometriosis D004715 29 associated lipids
Eye Neoplasms D005134 2 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Tian QX et al. [Effects of calcitonin on osteoblast cell proliferation and OPG/RANKL expression: experiment with mouse osteoblasts]. 2007 Zhonghua Yi Xue Za Zhi pmid:17785093
Wang YL et al. [Effect of estrogen-deficiency on expression of osteoprotegerin in alveolar bone: experiment with rats with periodontitis]. 2008 Zhonghua Yi Xue Za Zhi pmid:19024546
Wang BL et al. [Regulation of receptor activator of nuclear factor kappaB ligand and osteoprotegerin expression by prostaglandin E2 in osteoblastic-like cells]. 2008 Zhonghua Yi Xue Za Zhi pmid:19062743
Xiao XH et al. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro]. 2004 Zhonghua Yi Xue Za Zhi pmid:15730627
Wang M et al. [Bone mass change and its possible mechanisms in murine knockout apolipoprotein E(ApoE-/-)]. 2009 Zhonghua Yi Xue Za Zhi pmid:20137704
Zhang JH et al. [Effects of the osteoclast in pathogenesis of multiple myeloma]. 2007 Zhonghua Xue Ye Xue Za Zhi pmid:17877161
Zhao ZM et al. [The preliminary study on in vitro differentiation of human umbilical cord blood cells into neural cells]. 2003 Zhonghua Xue Ye Xue Za Zhi pmid:14575594
Xu ML et al. [An update for the research progress of osteoprotegerin on coronary artery disease]. 2011 Zhonghua Xin Xue Guan Bing Za Zhi pmid:22321243
Luo ZR et al. [A study of relationship between dialectical classification according to traditional Chinese medicine of acute coronary syndrome with serum osteoprotegerin and its ligand]. 2013 Zhonghua Wei Zhong Bing Ji Jiu Yi Xue pmid:24225213
Huang P et al. [In vitro study of combination rhOPG-Fc and alendronate on inhibition osteoclast]. 2005 Zhonghua Wai Ke Za Zhi pmid:16083587

Table of Content